Illumina, Inc. ILMN has announced a series of updates to its NovaSeq X Series. The company’s single-flow-cell NovaSeq X Sequencing System is now available for the first time, alongside the software v1 ...

Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced a series of ...

Illumina (ILMN) announced a series of updates to its NovaSeq X Series, delivering the NovaSeq X single-flow-cell system alongside a software ...

Technologic advancements in sequencing by synthesis (SBS) chemistry and bioinformatics, together with long-read sequencing assays that can deliver contiguous data up to 10Kb, expand the breadth of ...

Welcome to a new era for clinical labs. The NovaSeq ™ 6000Dx is Illumina's first IVD high-throughput sequencing instrument for the clinical lab. Push the boundaries of clinical genomics with ...

因美纳公司首席技术官Steve Barnard博士表示：“NovaSeq ...

A central focus for Illumina has been the transition to its NovaSeq X platform, which promises to reduce sequencing costs by approximately threefold. This transition, however, has not been without ...

The Genomics Core offers a wide range of genomic and DNA/RNA services. We operate the Illumina NovaSeq X Plus, NextSeq 550, and MiSeq platforms for all Next Generation Sequencing and offer an ...

Propel your research forward to impact the world, not the environment. The NovaSeq X and NovaSeq X Plus systems were purpose-designed to be our most sustainable sequencing systems with reductions ...

Sequencing giant Illumina Inc. ILMN is set to release third-quarter 2024 results on Nov. 4 after the closing bell. Stay up-to ...

A central focus for Illumina has been the transition to its NovaSeq X platform, which promises to reduce sequencing costs by approximately threefold. This transition, however, has not been without its ...